tiprankstipranks
Trending News
More News >
Scopus BioPharma (SCPS)
OTHER OTC:SCPS
US Market

Scopus BioPharma (SCPS) Ratios

Compare
67 Followers

Scopus BioPharma Ratios

SCPS's free cash flow for Q2 2023 was $0.00. For the 2023 fiscal year, SCPS's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.05 1.96 0.52 0.90-
Quick Ratio
0.05 1.96 0.52 0.04-
Cash Ratio
0.02 1.90 0.48 0.04-
Solvency Ratio
-1.56 -6.65 -3.04 -3.15-
Operating Cash Flow Ratio
-1.09 -2.74 -0.66 -2.48-
Short-Term Operating Cash Flow Coverage
0.00 0.00 -1.11 0.00-
Net Current Asset Value
$ -7.06M$ 4.01M$ -1.83M$ -86.52K-
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 1.16 0.00-
Debt-to-Equity Ratio
0.00 0.00 -1.25 0.00-
Debt-to-Capital Ratio
0.00 0.00 5.05 0.00-
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00-
Financial Leverage Ratio
-0.06 2.04 -1.08 -9.31-
Debt Service Coverage Ratio
0.00 -36.67 -3.63 0.00-
Interest Coverage Ratio
0.00 -35.67 -14.38 0.00-
Debt to Market Cap
0.00 0.00 0.01 0.00-
Interest Debt Per Share
0.00 0.04 0.22 0.00-
Net Debt to EBITDA
0.01 0.29 -0.04 0.01-
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%-
EBIT Margin
0.00%0.00%0.00%0.00%-
EBITDA Margin
0.00%0.00%0.00%0.00%-
Operating Profit Margin
0.00%0.00%0.00%0.00%-
Pretax Profit Margin
0.00%0.00%0.00%0.00%-
Net Profit Margin
0.00%0.00%0.00%0.00%-
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-
Net Income Per EBT
99.10%102.87%106.50%100.00%-
EBT Per EBIT
100.00%97.53%106.96%100.00%-
Return on Assets (ROA)
-2959.69%-338.65%-586.04%-348.58%-
Return on Equity (ROE)
911.69%-690.19%631.75%3246.42%-
Return on Capital Employed (ROCE)
165.88%-687.86%554.59%3246.42%-
Return on Invested Capital (ROIC)
164.39%-707.64%-2390.34%3246.42%-
Return on Tangible Assets
-2959.69%-338.65%-586.04%-348.58%-
Earnings Yield
-137594.60%-98.00%-5.83%-3.03%-
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00-
Payables Turnover
0.00 0.00 0.00 0.00-
Inventory Turnover
0.00 0.00 0.00 0.00-
Fixed Asset Turnover
0.00 0.00 0.00 0.00-
Asset Turnover
0.00 0.00 0.00 0.00-
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00-
Cash Conversion Cycle
0.00 0.00 0.00 0.00-
Days of Sales Outstanding
0.00 0.00 0.00 0.00-
Days of Inventory Outstanding
0.00 0.00 0.00 0.00-
Days of Payables Outstanding
0.00 0.00 0.00 0.00-
Operating Cycle
0.00 0.00 0.00 0.00-
Cash Flow Ratios
Operating Cash Flow Per Share
-0.39 -0.66 -0.19 -0.14-
Free Cash Flow Per Share
-0.39 -0.66 -0.19 -0.14-
CapEx Per Share
<0.01 <0.01 0.00 <0.01-
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00-
Dividend Paid and CapEx Coverage Ratio
-5.24K -5.72K 0.00 -498.80-
Capital Expenditure Coverage Ratio
-5.24K -5.72K 0.00 -498.80-
Operating Cash Flow Coverage Ratio
0.00 0.00 -1.11 0.00-
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00-
Free Cash Flow Yield
-48284.31%-40.39%-1.27%-2.40%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -1.02 -17.14 -32.96-
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00-
Price-to-Book (P/B) Ratio
>-0.01 7.04 -108.29 -1.07K-
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -2.48 -78.53 -41.73-
Price-to-Operating Cash Flow Ratio
>-0.01 -2.48 -78.53 -41.81-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 -0.01 -0.04 -0.11-
Price-to-Fair Value
>-0.01 7.04 -108.29 -1.07K-
Enterprise Value Multiple
<0.01 -0.74 -19.57 -32.95-
Enterprise Value
-107.74K 20.35M 198.76M 88.62M-
EV to EBITDA
<0.01 -0.74 -19.57 -32.95-
EV to Sales
0.00 0.00 0.00 0.00-
EV to Free Cash Flow
0.01 -1.78 -78.71 -41.71-
EV to Operating Cash Flow
0.01 -1.78 -78.71 -41.79-
Tangible Book Value Per Share
-0.33 0.23 -0.14 >-0.01-
Shareholders’ Equity Per Share
-0.31 0.23 -0.14 >-0.01-
Tax and Other Ratios
Effective Tax Rate
<0.01 -0.03 -0.07 >-0.01-
Revenue Per Share
0.00 0.00 0.00 0.00-
Net Income Per Share
-0.55 -1.61 -0.87 -0.18-
Tax Burden
0.99 1.03 1.07 1.00-
Interest Burden
1.00 1.03 0.00 0.00-
Research & Development to Revenue
0.00 0.00 0.00 0.00-
SG&A to Revenue
0.00 0.00 0.00 0.00-
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00-
Income Quality
0.69 0.42 0.23 0.79-
Currency in USD